<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 20)*
Abbott Laboratories
-----------------------------------------------------------
(Name of Issuer)
Common shares without par value
-----------------------------------------------------------
(Title of Class of Securities)
002824 10 0
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
(Continued on following page(s))
Page 1 of 11 Pages
<PAGE>
CUSIP No. 002824 10 0 13G Page 2 of 11 Pages
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- ------------------------------------------------------------------------------
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 0
---------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 107,072,842
---------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
---------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
107,072,842
---------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
107,072,842
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
EP
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 3 of 11 Pages
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gary P. Coughlan
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
263,457 shares - (Does not include shares held
NUMBER OF direct in the Abbott Laboratories
Stock Retirement Trust for
the benefit of the reporting
person.)
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 110,068,668 - See Attached Exhibit 1
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 263,457 shares (see note in 5 above)
PERSON direct
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
110,068,668 - as Co-Trustee, Abbott
Laboratories Stock Retirement
Trust.
----------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,591,175 - (Total of 5 + 6 + 259,050 shares - right to acquire
by exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.3%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 4 of 11 Pages
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas C. Freyman
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
56,242 shares - (Does not include shares held in
NUMBER OF direct the Abbott Laboratories
Stock Retirement Trust for the
benefit of the reporting person.)
----------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 110,068,668 - See Attached Exhibit 1
----------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 56,242 shares (see note in 5 above)
PERSON direct
----------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
110,068,668 - as Co-Trustee, Abbott Laboratories
Stock Retirement Trust.
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,258,812 - (Total of 5 + 6 + 133,902 shares - right to acquire
by exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.3%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 002824 10 0 13G Page 5 of 11 Pages
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ellen M. Walvoord
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
5 SOLE VOTING POWER
168,900 shares - (Does not include shares held in
NUMBER OF direct the Abbot Laboratories
Stock Retirement Trust for the
benefit of the reporting person.)
---------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 110,068,668 - See Attached Exhibit 1
---------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 168,900 shares (see note in 5 above)
PERSON direct
---------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
110,068,668 - as Co-Trustee, Abbott Laboratories
Stock Retirement Trust.
- ------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
110,376,175 - (Total of 5 + 6 + 138,607 shares - right to acquire
by exercise of stock options.)
- ------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
- ------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.3%
- ------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
Abbott Laboratories
Item 1(b) Address of Issuer's Principal Executive Offices:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(a) Name of Persons Filing:
Abbott Laboratories Stock Retirement Trust
Gary P. Coughlan
Thomas C. Freyman
Ellen M. Walvoord
Item 2(b) Address of Principal Business Office:
100 Abbott Park Road
Abbott Park, Illinois 60064-3500
Item 2(c) Citizenship:
Abbott Laboratories Stock Retirement Trust - Illinois.
Gary P. Coughlan, Thomas C. Freyman, and
Ellen M. Walvoord - United States
Item 2(d) Title of Class of Securities:
Common shares without par value
Item 2(e) CUSIP Number:
002824 10 0
Item 3. If this statement is filed pursuant to Section 240.13d-1(b)
or 240.13d-2(b), check whether the person filing is an:
[X] Employee Benefit Plan or endowment fund in accordance
with Section 240.13d-1(b)(ii)(F).
Page 6 of 11 pages
<PAGE>
Item 4. Ownership
(a) (See cover pages 2, 3,
(b) 4 and 5, Items 5 through
(c) 9 and 11.)
Item 5. Ownership of Five Percent or Less of a Class
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
The shares owned by the Abbott Laboratories Stock Retirement
Trust and the dividends thereon are held for the benefit of
participants of the Abbott Laboratories Stock Retirement
Plan pursuant to terms of that Plan and the Trust. The
Abbott Laboratories Stock Retirement Plan is a qualified
profit sharing plan. As of December 31, 1998, there were
36,364 participants with share balances in the Plan.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent
Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct. This statement is filed on behalf of each individual listed
below pursuant to their agreement.
Date: February 10, 1999
/s/ Gary P. Coughlan ABBOTT LABORATORIES STOCK
- --------------------- RETIREMENT TRUST
Gary P. Coughlan
/s/ Thomas C. Freyman
- ---------------------
Thomas C. Freyman
/s/ Ellen M. Walvoord /s/ Thomas C. Freyman
- --------------------- ------------------------------
Ellen M. Walvoord Thomas C. Freyman, Chairman of
Trustees, Abbott Laboratories
Stock Retirement Trust
Page 7 of 11 pages
<PAGE>
EXHIBIT 1
Schedule 13G
Amendment No. 20
Abbott Laboratories
Common shares without par value
CUSIP Number 002824 10 0
Messrs. Coughlan and Freyman and Ms. Walvoord are Co-trustees of the Abbott
Laboratories Stock Retirement Trust, committee members of a committee
established under the Abbott Laboratories Stock Retirement Trust (Puerto
Rico), Trustees of the Abbott Laboratories Employee Benefit Trust, and
members of the Abbott Stock Committee for the Abbott Laboratories Ashland
Union 401(k) Trust. As such, each of them has shared voting power over the
110,068,668 shares held by those trusts. This total is comprised of the
following components:
<TABLE>
<CAPTION>
Number of Shares Name of Trust
---------------- -------------
<S> <C>
107,072,842 Abbott Laboratories Stock Retirement Trust
2,918,829 Abbott Laboratories Stock Retirement Trust
(Puerto Rico)
52,000 Abbott Laboratories Employee Benefit Trust
24,997 Abbott Laboratories Ashland Union 401(k) Trust
</TABLE>
Page 8 of 11 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 20 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Gary P. Coughlan
------------------------------
Gary P. Coughlan
Date: February 10, 1999
Page 9 of 11 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 20 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which he would not otherwise be deemed to be
beneficial owner.
/s/ Thomas C. Freyman
------------------------------
Thomas C. Freyman
Date: February 10, 1999
Page 10 of 11 Pages
<PAGE>
Disclaimer of Beneficial Ownership
under Rule 13d-4
----------------------------------
The filing of Schedule 13G Amendment 20 on behalf of the Abbott Laboratories
Stock Retirement Trust does not constitute an admission that the undersigned
is, for purposes of Section 13(d) of the Securities and Exchange Act of 1934,
the beneficial owner of any securities covered by the Schedule. Pursuant to
Rule 13d-4 of the Act, the undersigned disclaims such ownership with respect
to any shares listed therein of which she would not otherwise be deemed to be
beneficial owner.
/s/ Ellen M. Walvoord
----------------------------
Ellen M. Walvoord
Date: February 10, 1999
Page 11 of 11 Pages
